do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance Frontiers The effect of DPP-4 inhibitors,
Description
This approach can also result in increased production of other hormones produced by L-cells such as oxyntomodulin and peptide YY (PYY), which can enhance the metabolic effects of GLP-1

Turner DS, Etheridge L, Jones J, Marks V, Meldrum B, Bloom SR, et al

This is your starting point

Fiorucci S, Scionti L, Bosso R, et al

Lixisenatide: A New Daily GLP-1 Agonist for Type 2 Diabetes Management

GIP, glucose-dependent insulinotropic polypeptide
00174-1/asset/4ff9bb50-3a8f-4946-a683-db1579705072/main.assets/gr1.jpg)